Get started

TA

WVE Technical Analysis 🧙WAVE Life Sciences Ltd is a preclinical biopharmaceutical company based in Singapore. It owns a diverse pipeline of nucleic acid therapeutics meant to address rare genetic diseases related to the central nervous system, muscles, eyes, liver, and skin. Its nucleic acid therapeutics target genetic defects to either reduce the expression of disease-promoting proteins or transform the production of dysfunctional mutant proteins into the production of functional proteins. If you want more trading ideas like this one ,🎯 press a thumb up! 👍 Have a question? Don't be shy to ask! 🤓 Interested to study how to analyze charts, follow me!
NASDAQ:WVELong
by yura_trades
MATIC about to explode!Here's a quick look at Matic 4 hr chart. As we can see, the price has been oscillating in the falling wedge and is about to break it. This will probably be a catalyst to a bigger move. Note: We've got bullish divergence, which is a bullish sign! The idea is: Buy the breakout from the bigger falling wedge and Take profits at the levels shown in the chart. Targets: 1. 0.37$ 2. 0.43$ 3. 0.46$ 4. 0.5$ 5. 0.55$ 6. 0.63$ Follow me for daily trading setups BTC dictates the market. If BTC falls, then Alts will fall as well. BTC needs to get stable before alts can run. Trade safe!
MLong
by MBM_Crypto
Polkadot DOT Bullish Case 2021 BullrunWHY DOT - I believe we are entering the part of the bull run where market cap takes precedence over other analysis. - I believe Dot is in a perfect place at 35B entering the super cycle. - Dot gets compared to ETH very often. - ETH & DOT have one important thing in common from one another... TIME - ETH launched right before the last bull run. DOT launched right before this bull run. - Only draw back is that DOT is unavailable on Coinbase. - The risk/ reward on DOT is that it can pull a run just like ETH did. I am willing to take that chance. - The use case is solid and has a lot of potential. - Can Dot reach 100B or even 300B this bull run? I don't think that is too crazy. - I will be posting analysis of other low cap alts that have a chance at great success right now in this phase. Comment in below for discussion & like if you liked. CHART ANALYSIS - I was told to further explain my charts. - Above on the graph I have a very basic pennant drawn. What makes this pennant unique is that its been holding structure for 3 months straight. - Each time the price has touched in the green circle, price has bounced into discovery. Not to mention it also holding the same moving average ADA has... bullish - Below I have the MACD. MACD is showing a bullish cross with significant upward buying preasure. - Regular RSI is in the middle. It shows where exactly the coin is in volatility. In this case RSI has formed a bullish support band. Has long has we stay above this band price should go into discovery. The higher the more volatility which is good in bull markets. - Below, the Stoch RSI. It show very short term price action direction. Very dependable in entering a position. The goal here would to have the Stoch RSI float high as the regular RSI picks up. The TA & pumpology is strong with DOT. Very excited to see how it performs this year. A quality Alt coin that deserves to mentioned with ETH ADA VET
Long
by AthenticWhale1
1
BCLI Technical Analysis 🧙Brainstorm Cell Therapeutics Inc is a biotechnology company. The company is developing novel adult stem cell therapies for debilitating neurodegenerative disorders such as Amyotrophic Lateral Sclerosis (ALS, also known as Lou Gehrig's disease), Progressive Multiple Sclerosis (PMS), and Parkinson's disease (PD). Brainstorm's NurOwn, its proprietary process for the propagation of Mesenchymal Stem Cells (MSC) and differentiation into neurotrophic factor-(NTF) secreting cells (MSC-NTF), and their transplantation at, or near, the site of damage, offers the hope of more effectively treating neurodegenerative diseases. If you want more trading ideas like this one ,🎯 press a thumb up! 👍 Have a question? Don't be shy to ask! 🤓 Interested to study how to analyze charts, follow me!
NASDAQ:BCLILong
by yura_trades
EPZM Technical Analysis 🧙Epizyme Inc is a clinical-stage biopharmaceutical company that is committed to rewriting treatment for cancer and other serious diseases through discovering, developing and commercializing novel epigenetic medicines. Its product candidates include tazemetostat, an inhibitor of the EZH2, which is in Phase II clinical trial for patients with relapsed or refractory non-hodgkin lymphoma (NHL), Phase II clinical trial for relapsed or refractory patients with mesothelioma, Phase I dose-escalation and expansion study for children with INI1-negative solid tumors. The company is also developing additional programs, such as pinometostat, an intravenously administered small molecule inhibitor of DOT1L for the treatment of acute leukemias and PRMT5 inhibitor. If you want more trading ideas like this one ,🎯 press a thumb up! 👍 Have a question? Don't be shy to ask! 🤓 Interested to study how to analyze charts, follow me!
ELong
by yura_trades
1
PSXP Technical Analysis 🧙Phillips 66 Partners is a master limited partnership that provides fee-based transportation, processing, storage, and fractionation services primarily to Phillips 66, which owns a 74% limited partner interest. Phillips 66 Partners’ primary revenue sources are long-term, fee-based contracts to handle crude, natural gas liquids, and refined products. Phillips 66 manages and operates Phillips 66 Partners as its noneconomic general partner. Phillips 66’s general partner economic interest and incentive distribution rights were eliminated in August 2019. If you want more trading ideas like this one ,🎯 press a thumb up! 👍 Have a question? Don't be shy to ask! 🤓 Interested to study how to analyze charts, follow me!
PLong
by yura_trades
6
FGEN Technical Analysis 🧙FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates. If you want more trading ideas like this one ,🎯 press a thumb up! 👍 Have a question? Don't be shy to ask! 🤓 Interested to study how to analyze charts, follow me!
NASDAQ:FGENLong
by yura_trades
APT Technical Analysis 🧙Alpha Pro Tech Ltd is involved in the business of developing, manufacturing, and marketing of disposable protective apparel, building supply, and infection control products principally in the United States. It operates its business through segment which includes Building Supply, Disposable Protective Apparel and Infection Control. It mainly offers a line of construction supply weatherization products, namely house wrap and synthetic roof underlayment as well as other woven material, different styles of disposable products like shoe covers, bouffant caps, gowns, coveralls, lab coats, frocks and other miscellaneous products. It also provides face masks and eye shields. It generates most of its revenues from the sale of products across the United States. If you want more trading ideas like this one ,🎯 press a thumb up! 👍 Have a question? Don't be shy to ask! 🤓 Interested to study how to analyze charts, follow me!
AMEX:APTLong
by yura_trades
AFIB Technical Analysis 🧙Acutus Medical Inc is an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated. The company designs, manufactures and markets a range of tools for catheter-based ablation procedures to treat various arrhythmias. Its product portfolio includes novel access sheaths, transseptal crossing tools, diagnostic and mapping catheters, ablation catheters, mapping and imaging consoles and accessories, as well as supporting algorithms and software programs. It markets and sells its electrophysiology products worldwide to hospitals and electrophysiologists that treat patients with arrhythmias. Its operates in United States and Europe with majority of the revenue generating from Europe. If you want more trading ideas like this one ,🎯 press a thumb up! 👍 Have a question? Don't be shy to ask! 🤓 Interested to study how to analyze charts, follow me!
ALong
by yura_trades
ADVM Technical Analysis 🧙Adverum Biotechnologies Inc is a US-based clinical-stage gene therapy company. It develops gene therapy product candidates intended to provide durable efficacy by inducing sustained expression of a therapeutic protein. The company has primarily generated revenue through license, research and collaboration arrangements with its strategic partners. Its lead product candidate is ADVM-022 which is a single, in-office intravitreal (IVT) injection gene therapy designed to deliver long-term durability with treatment response, reduce the treatment burden of frequent anti-vascular endothelial growth factor (anti-VEGF) injections, and improve real-world vision outcomes for patients. If you want more trading ideas like this one ,🎯 press a thumb up! 👍 Have a question? Don't be shy to ask! 🤓 Interested to study how to analyze charts, follow me!
NASDAQ:ADVMLong
by yura_trades
BNB - Might run up to ATH soon. Here's a quick look at BNB 4 hr chart. Not long before we see a bigger move - Probably to the upside. As we can observe, the price broke out from the big sym. triangle and is now forming a bigger bull flag. If it breaks to the upside, it is then very likely that we see a run up to new ATH - 450$ next ATH The idea is: Buy the breakout from the level shown in the chart. Take profits at the level shown in the chart. Targets: 1. 308$ 2. 347$ 3. 450$ Follow me for daily trading setups - Telegram group will be available soon BTC dictates the market. If BTC falls, then Alts will fall as well. BTC needs to get stable before alts can run. Trade safe!
Long
by MBM_Crypto
6
EPZM Technical Analysis 🧙Epizyme Inc is a clinical-stage biopharmaceutical company that is committed to rewriting treatment for cancer and other serious diseases through discovering, developing and commercializing novel epigenetic medicines. Its product candidates include tazemetostat, an inhibitor of the EZH2, which is in Phase II clinical trial for patients with relapsed or refractory non-hodgkin lymphoma (NHL), Phase II clinical trial for relapsed or refractory patients with mesothelioma, Phase I dose-escalation and expansion study for children with INI1-negative solid tumors. The company is also developing additional programs, such as pinometostat, an intravenously administered small molecule inhibitor of DOT1L for the treatment of acute leukemias and PRMT5 inhibitor. If you want more trading ideas like this one ,🎯 press a thumb up! 👍 Have a question? Don't be shy to ask! 🤓 Interested to study how to analyze charts, follow me!
ELong
by yura_trades
purple star?could be a purple star rocket ship moment, or I could be wrong. Just doing TA on the 4hr, and that's what I see. But for XTZ to fail I assume BTC would lead the way; how will we pay off our countries debt if not through cryptocurrencies. Not Financial Advice but even if you have 0 debt in USA your 60K+ in debt soo lets get on with it and make paper obsolete, just pay us in crypto so it saves us the hassle of going to the bank. strong resistance at $5.5... if BTC is going to 65K then XTZ can break $5.5
COINBASE:XTZUSDLong
by Ncard137